
The world's first Polyimide (PI)-based closed aerosol drug delivery platform. Specially engineered for patients requiring mechanical ventilators or other positive pressure/high-flow respiratory support circuits, its expanded mist reservoir design significantly enhances lung deposition rates.
During nebulization, aerosol particles are highly susceptible to electrostatic attraction, causing them to adhere to metal surfaces. Utilizing PI material minimizes static generation and reduces drug residue on circuit surfaces, thereby maximizing aerosol output and inhalation efficiency.
Polyimide (PI) undergoes elastic deformation under fluid pressure, mitigating abrupt flow velocity changes and reducing shear rates. Unlike rigid metals, it prevents damage caused by amplified instantaneous stress.
PI’s low thermal conductivity ensures that heat does not accumulate on the working surface. This prevents localized hot spots, significantly reducing the risk of damaging sensitive bio-substances.
With higher hydrophobicity than metals, PI minimizes protein and lipid adsorption, thereby inhibiting the degradation caused by interfacial shear stress.
PI is chemically inert and non-metallic. It does not release metal ions during nebulization, ensuring that the properties of biological molecules or liposomes remain intact.
The high processability of PI allows for the fabrication of precise microporous structures, ensuring product consistency and exceptional performance for high-accuracy nebulization needs.
Effectively delivers aerosolized medications to patients during Invasive Mechanical Ventilation (IMV).

Directly compatible with CPAP (Continuous Positive Airway Pressure) and BiPAP (Bilevel Positive Airway Pressure). Can be integrated without supplementary flow or interrupting the therapy cycle.

Allows in-line drug administration without treatment interruption. Maintaining a closed respiratory circuit effectively reduces infection risks and improves therapeutic efficiency.




The closed-circuit design minimizes the risk of exposure to pathogens.
Effective drug utilization through low residue and high inhalation efficiency.
Compared to metered-dose inhalers (MDIs), ICU length of stay is reduced by 28%. Compared to jet nebulizers, exposure is reduced by 14%.¹
1. Source: CADTH Health Technology Review (2021)

① Connect the AC/DC power adapter to the power outlet.

② Connect the USB controller to the power adapter.

③ Check the blue light on the USB controller is on.

④ Plug the nebulizer cable to the nebulizer.
| Model | MB05T01 |
| Method of operation | Active Vibrating Mesh Technology |
| Power Supply | AC/DC Adapter: - Please use a power adapter that meets the requirements of IEC60601-1 and CCC certification standards. - Specification: 5V DC, 1A |
| Vibration Freq. | Approx. 120 (kHz) ±10% |
| Nebulization Rate | ≥ 0.2 mL / min |
| Particle Size | MMAD ≤ 5μm |
| Capacity of Nebulizer | Maximum 6 mL |
| Intended user | 29 days Neonatal or older and adult. Operator must be legally practicing medical personnel. |
| Operating Env. | Temp: 10°C - 40°C; RH: 30 - 85%; Pressure: 800 - 1060hPa |
| Storage Env. | Temp: -20 - 70°C; RH: 20 - 75%; Pressure: 800 - 1060hPa |
| Service Life | 28 days (4 treatments per day). |
| Weight | USB Controller: Approx. 100g Medication Cup: Approx. 6.5g |
| Kit Contents | USB Controller, T-Piece, Nebulizer and Adapter. |